Juvenile pemphigus vulgaris: efficacy of moderate doses of deflazacort.
A 13-year-old girl with pemphigus vulgaris (PV) had clinical features of chronic stomatitis. The histologic and immunologic findings were typical of a diagnosis of PV. Good therapeutic results were obtained with moderate doses of deflazacort, 1 mg/kg/day slowly tapered to 0.1 mg/kg every other day. The patient had no significant side effects.
Fimiani
M
M
Department of Dermatology, University of Siena, Italy.
Pianigiani
E
E
Castelli
A
A
D000293:Adolescent; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D011282:Pregnenediones / Q000008:administration & dosage / Q000627:therapeutic use*; D012074:Remission Induction
D000893:Anti-Inflammatory Agents; D011282:Pregnenediones; C021988:deflazacort